stockrowInteger Holdings Corporation
ITGR Healthcare Medical Devices
Integer Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, up 7.98% from fiscal 2024.
- Revenue
- −3.86%
- EPS
- −61.0%
- Free cash flow
- −65.2%
- Total debt
- +4.06%
Quarter to September 2026, against a year earlier
Follow ITGR
Alert me
Integer Holdings Corporation (ITGR) Net income
Integer Holdings Corporation's net income for fiscal 2025 was $102.8M, down 14.3% from $119.9M in fiscal 2024. Over the twelve months to 30 September 2026 it was $103.7M. Over the past ten years it has ranged from −$7.6M (fiscal 2015) to $168.0M (fiscal 2018); the current reading is higher than 82% of that period. Integer Holdings Corporation ranks 21st of 149 Medical Devices companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | $102.8M | (14.25%) |
| FY2024 | $119.9M | 32.26% |
| FY2023 | $90.7M | 36.57% |
| FY2022 | $66.4M | (31.43%) |
| FY2021 | $96.8M | 25.30% |
| FY2020 | $77.3M | (19.80%) |
| FY2019 | $96.3M | (42.64%) |
| FY2018 | $168.0M | 151.90% |
| FY2017 | $66.7M | 1,018.59% |
| FY2016 | $6.0M | — |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Sep 2026 | $15.0M | (36.55%) |
| Jun 2026 | $23.6M | 43.01% |
| Mar 2026 | $16.5M | (66.04%) |
| Dec 2025 | $48.6M | 22.51% |
| 43 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| LIVN LivaNova PLC compare | $196.1M |
| TMDX TransMedics Group, Inc. compare | $144.5M |
| HAE Haemonetics Corporation compare | $103.9M |
| ITGR Integer Holdings Corporation | $103.7M |
| UFPT UFP Technologies, Inc. compare | $72.3M |
| AXGN AxoGen, Inc. compare | −$31.9M |
| IRTC iRhythm Holdings, Inc. compare | −$38.6M |
| NEOG Neogen Corporation compare | −$56.1M |
| TXG 10x Genomics compare | −$75.1M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on ITGR
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement